G-protein-coupled receptors (GPCRs) are essential components of the signalling network throughout the body. To understand the molecular mechanism of G-protein-mediated signalling, solved structures of receptors in inactive conformations and in the active conformation coupled to a G protein are necessary 1,2 . Here we present the structure of the adenosine A 2A receptor (A 2A R) bound to an engineered G protein, mini-G s , at 3.4 Å resolution. Mini-G s binds to A 2A R through an extensive interface (1,048 Å 2 ) that is similar, but not identical, to the interface between G s and the β 2 -adrenergic receptor 3 . The transition of the receptor from an agonist-bound active-intermediate state 4,5 to an active G-proteinbound state is characterized by a 14 Å shift of the cytoplasmic end of transmembrane helix 6 (H6) away from the receptor core, slight changes in the positions of the cytoplasmic ends of H5 and H7 and rotamer changes of the amino acid side chains Arg 3.50 , Tyr 5.58 and Tyr 7.53 . There are no substantial differences in the extracellular half of the receptor around the ligand binding pocket. The A 2A R-mini-G s structure highlights both the diversity and similarity in G-protein coupling to GPCRs 6 and hints at the potential complexity of the molecular basis for G-protein specificity.
| Ligand binding and overall structure of the A 2A R-mini-G s complex. a, The structure of A 2A R is depicted as a cartoon in rainbow coloration (N terminus in blue, C terminus in red) with mini-G s in purple. The agonist NECA bound to A 2A R and GDP bound to mini-G s are depicted as space-filling models (carbon, yellow; nitrogen, blue; oxygen, red; phosphorous, orange). Relevant secondary structural features are labelled. b, Mini-G s increases the affinity of agonist binding to A 2A R similar to that observed by a heterotrimeric G protein.
Competition binding curves were performed in duplicate (n = 3) by measuring the displacement of the inverse agonist 3 H-ZM241385 with increasing concentrations of the agonist NECA (K i values in parentheses, see Extended Data Fig. 1 for full data): blue circles, A 2A R (K i 4.6 ± 0.3 μ M); orange squares, A 2A R and mini-G s (K i 430 ± 80 nM); green diamonds, A 2A R and heterotrimeric G protein with nanobody Nb35 (K i 340 ± 70 nM). Error bars represent s.e.m. G proteins were all added to membranes containing A 2A R to give a final concentration of 25 μ M and the final concentration of NaCl was 100 mM (see Methods). c, The structure of β 2 AR (green) bound to G s (grey and purple) is depicted as a cartoon in the same orientation as A 2A R in a; the purple region in G s corresponds to the structure of mini-G s . S1 S S1 Letter reSeArCH increase in agonist affinity that occurred upon incubation of the receptor in the presence of the heterotrimeric G protein G s and it also showed identical sensitivity to the presence of the allosteric antagonist Na + ( Fig. 1 and Extended Data Fig. 1 ). In addition, mini-G s readily formed a complex with A 2A R in the presence of the agonist NECA and the complex was considerably more thermostable, particularly in 
H5 H7 H8 CL2 H6 1 0 2 1 0 5 1 0 6 1 0 7 1 0 9 1 1 0 1 1 1 1 1 2 2 0 0 2 0 3 2 0 7 2 0 8 2 1 0 2 2 7 2 3 1 2 3 5 2 9 1 2 9 2 2 9 3 2 9 6 Labelling of amino acid residues shows the Ballesteros-Weinstein numbers for the receptors and the CGN notation for G proteins. f, g, Views of the cytoplasmic surface of A 2A R and β 2 AR, respectively, as space-filling models with atoms making contacts with their respective G proteins coloured according to their type; carbon, green; nitrogen, blue; oxygen, red. Atoms coloured pink comprise conserved hydrophobic residues in the core of the receptors against which Arg 3.50 packs. h, Comparison of residues making contacts to G proteins in the A 2A R-mini-G s complex and the β 2 AR-G s complex. Amino acid residues in the receptors that make contacts are coloured: red, negatively charged; blue, positively charged; green, hydrophobic; yellow, hydrophilic. Residues in white are those that do not make contact to the respective G protein, but the equivalent residue in the other receptor does. Ballesteros-Weinstein (B-W) numbers are given for residues in transmembrane α -helices, with a dash for residues in loops or H8. Amino acid residues 5.71-5.77 are disordered in the A 2A R-mini-G s structure.
Letter reSeArCH short-chain detergents, than A 2A R with only NECA bound (Extended Data Fig. 2 ). This complex was crystallized in the detergent octylthioglucoside by vapour diffusion, a data set collected from two crystals, the structure determined by molecular replacement (see Methods) and refined to 3.4 Å (Extended Data Table 1 ). Of the two A 2A Rmini-G s complexes per crystallographic asymmetric unit, the density in complex AC was better defined and was therefore used for all subsequent analyses below (see Supplementary Discussion) .
The A 2A R-mini-G s complex contained density for the agonist NECA bound to A 2A R and density for a molecule of GDP bound to mini-G s (Extended Data Fig. 3 ). The presence of GDP in the mini-G s structure is a reflection of the properties of the engineered G protein, which, after complex formation, is insensitive to GTP γs -mediated dissociation (B.C. and C.G.T., manuscript submitted). Mini-G s is in a conformation virtually identical to that observed in the β 2 AR-G s structure (see below) and therefore represents an active state of the G protein, consistent with its ability to couple to A 2A R and induce high-affinity agonist binding (Fig. 1 ). The interface between A 2A R and mini-G s is formed between 20 amino acid residues from the receptor and 17 residues in mini-G s (Fig. 2 Table 1 ), comprising a total buried surface area of 1,048 Å 2 on the receptor. In mini-G s , contacts are made predominantly by the α 5 helix involving 14 amino acid residues that pack against residues in H3, cytoplasmic loop 2 (CL2), H5, H6, H7 and H8 of A 2A R. Additional interactions include residues in S1, S3, the S2-S3 loop and α 5 that form a hydrophobic pocket in which the side chain Leu110 in CL2 of A 2A R is sequestered (Extended Data Fig. 7 ). Amino acid residues in A 2A R and mini-G s form complementary surfaces that pack together predominantly via van der Waals interactions (~ 90% of contacts) with six polar interactions across the interface. Helix α 5 protrudes into the cleft within the cytoplasmic face of A 2A R created through the outward bending of the cytoplasmic end of H6. The apex of the α 5 helix, Tyr391 H5. 23 (superscript refers to the CGN system for G proteins 6 ) makes extensive van der Waals interactions with Arg102 3.50 (superscript refers to the Ballesteros-Weinstein numbering system for GPCRs 19 ) that forms the whole upper surface of the cleft (Fig. 3) .
, Extended Data Figs 4-6 and Supplementary
Superposition of the receptors in the A 2A R-mini-G s complex and the β 2 AR-G s complex 3 shows that the receptors have very similar architectures (r.m.s.d. 1.7 Å over 1,239 atoms). The intracellular faces of the receptors align very well, including the large outward shift of the cytoplasmic end of H6 on activation. However, mini-G s does not superimpose exactly on the Gα subunit of the heterotrimeric G protein bound to β 2 AR ( Fig. 3 ). There is a difference in orientation of ~ 15°, although the difference is smaller (~ 10°) for the α 5 helix. This is probably a consequence of the different amino acid residues in A 2A R compared to β 2 AR ( Fig. 3 and Extended Data Fig. 5 ), which results in a slightly different packing of the G proteins to the receptors, although we cannot discount the possible influence of lattice contacts. Alignment of mini-G s with Gα s bound to β 2 AR shows that they are essentially identical (r.m.s.d. 0.92 Å over 1,158 atoms), with the most substantial difference being an 8° tilt between the respective α 5 helices, resulting in a 3.7 Å displacement of the C α of Tyr391 in mini-G s away from the core of the G protein (Extended Data Fig. 8 ). Overall, there are 14 contacting residues in common between the β 2 AR-G s complex and the A 2A Rmini-G s complex, with an additional 6 contacting residues present only in A 2A R and another ten present only in β 2 AR (Supplementary Table 1 ). Many of the contacts between residues in the α 5 helix of the G protein and the receptors are conserved, although the exact orientation and atomic contacts may differ ( Fig. 3 , Extended Data Fig. 6 , Supplementary  Table 1 ). Similarly, there is a highly conserved interaction between a hydrophobic residue in the centre of CL2, Leu110 in A 2A R and Phe139 in β 2 AR, and residues His41 S1.2 , Val217 S3.1 and Asp215 s2s3.1 in Gα s (Extended Data Fig. 7 ). The main difference between the A 2A R-mini-G s interface compared to the β 2 AR-G s interface occurs as a result of the different amino acid sequences at the H7-H8 boundary. In A 2A R, H7 terminates with Arg291 7.56 and forms the sequence R 7.56 IREFR (bold Letter reSeArCH amino acid residues make contact with mini-G s ), compared to the sequence S 7.56 PDFRI in the equivalent position of β 2 AR, where none of the residues make contacts with Gα s . Another region of the receptors that differs in the presence/absence of contacts to their respective G proteins is at the end of H5, owing to the extension of H5 in β 2 AR by an additional turn compared to A 2A R (Fig. 3 , Extended Data Fig. 6 and Supplementary Table 1 ). From these examples it is clear that although the majority of amino acid residues at the interface between the receptor and G protein are identical, the specific atoms involved in the contacts differ either in terms of the amino acid side chains involved, their relative dispositions at the interface and/or the nature of the interaction.
Comparison of the active-intermediate state of UK432097-bound A 2A R 5 with the structure of A 2A R bound to mini-G s identified major rearrangements in the cytoplasmic half of the receptor core to accommodate G-protein binding ( Fig. 4 ) and will be described in terms of the rearrangements required to transition from the activeintermediate state to the activated G-protein-bound conformation. First, the cytoplasmic end of H6 moves away from the receptor core by 14 Å as measured between the Cα atoms of Thr224 6.26 in the two different conformations. This movement is achieved through H6 bending outwards with little discernible rotation around the helix axis. The extent of H6 movement is dictated by van der Waals interactions between Lys227 6.29 , Ala231 6.33 and Leu235 6.37 in A 2A R and Leu393 H5. 25 and the carboxy terminus of mini-G s . The movement of H6 requires substantial changes in the packing of the cytoplasmic end of H6 with helices H5 and H7. In particular, the side chains of highly conserved Tyr197 5.58 and Tyr288 7.53 both adopt new rotamers to fill the space previously occupied by the side chains of Leu235 6.37 (the Cα of which moves by 3.7 Å) and Ile238 6.40 (Cα moves by 2.2 Å), respectively. The shift in Tyr288 7.53 allows Arg102 3.50 of the conserved DRY motif to adopt a fully extended conformation, packing against the side chain of Tyr391 H5.23 in the α 5 helix of mini-G s . It is notable that the structural change from the inactive conformation to the active-intermediate state 4 is characterized by the concerted rotation of H5, H6 and H7, whereas the conformation change from the activeintermediate state to the active conformation upon mini-G s binding is characterized by the bending of H6 with little further rotation. In contrast to the considerable rearrangements of the cytoplasmic half of the receptor, there are no substantial changes in the extracellular half of the receptor (Fig. 4 , Extended Data Fig. 9 ). Thus, the disposition of the ligand binding pocket described in the active-intermediate state most likely describes the high-affinity state of NECA bound to A 2A R.
A 2A R appears to have a very different energy landscape to the β -adrenergic receptors (β ARs). Both A 2A R and β 2 AR exist in an ensemble of conformations whether bound to antagonists, agonists or to no ligand at all, and the presence of agonists increases the probability of formation of a fully active state 20, 21 . This active state is then stabilized by binding of a G protein 3, 22 . Structures of β ARs bound to agonists are all in a conformation very similar to the inactive state 23, 24 , whereas structures of A 2A R bound to agonists are in an active-intermediate state 4, 5, 10 very similar to the active state. Whether there is an activeintermediate state for β ARs equivalent to A 2A R is unknown, but recently, it has been proposed based on extensive electron paramagnetic resonance spectroscopy data that β 2 AR also exists in two distinct states in the active conformation 20 . This work shows that the activeintermediate and fully active states are distinct conformations in the intracellular half of the receptor. Given the highly conserved nature of the mechanism of GPCR activation, it is likely that the activeintermediate of A 2A R may represent a common intermediate for many class A GPCRs, although it may exist only transiently depending on the energy landscape of the receptor.
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No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Expression and purification of mini-G s . The mini-G s construct used (construct 414) was identical to mini-G s (construct 393) described elsewhere (B.C. and C.G.T., manuscript submitted), except that one additional mutation, L63Y, was included to improve crystal quality. An N-terminal histidine tag (His 6 ) and TEV protease cleavage site were present to facilitate purification. Mini-G s was expressed in E. coli strain BL21(DE3)RIL upon induction with IPTG (50 μ M) for 20 h at 25 °C. Cells were harvested by centrifugation and lysed by sonication in lysis buffer (40 mM HEPES pH 7.5, 100 mM NaCl, 10% glycerol, 10 mM imidazole, 5 mM MgCl 2 , 50 μ M GDP, 1 mM PMSF, 2.5 μ M Pepstatin-A, 10 μ M Leupeptin, 50 μ g/ml DNase I, 100 μ g/ml lysozyme, 100 μ M DTT), supplemented with Complete protease inhibitors (Roche). The lysate was clarified by centrifugation and loaded onto a 10 ml Ni 2+ Sepharose FF column. The column was washed with wash buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 40 mM imidazole, 10% glycerol, 1 mM MgCl 2 , 50 μ M GDP) and eluted with elution buffer (20 mM HEPES pH 7.5, 100 mM NaCl, 500 mM imidazole, 10% glycerol, 1 mM MgCl 2 , 50 μ M GDP). TEV protease was added and the sample was dialysed overnight against dialysis buffer (20 mM HEPES pH 7.5, 100 mM NaCl, 10% glycerol, 1 mM MgCl 2 , 10 μ M GDP). TEV protease was removed by negative purification on Ni 2+ -NTA resin (Qiagen). The sample was concentrated to 1.5 ml and loaded onto a Superdex-200 26/600 gel-filtration column, equilibrated with gel-filtration buffer (10 mM HEPES pH 7.5, 100 mM NaCl, 10% glycerol, 1 mM MgCl 2 , 1 μ M GDP, 0.1 mM TCEP). Peak fractions were pooled and concentrated to 100 mg/ml. The pure protein was aliquoted, flash-frozen in liquid nitrogen, and stored at − 80 °C. A typical yield was 100 mg of pure mini-G s per litre of culture. Expression and purification of adenosine A 2A R. Wild-type human adenosine A 2A R (residues 1-308) was modified to contain a C-terminal histidine tag (His 10 ) and TEV protease cleavage site. The N154A mutation was introduced to remove a potential N-linked glycosylation site. Recombinant baculoviruses expressing A 2A R were prepared using the flashBAC ULTRA system (Oxford Expression Technologies). Trichoplusia ni cells were grown in suspension in ESF921 media (Expression Systems) to a density of 3 × 10 6 cells/ml, infected with A 2A R baculovirus and incubated for 72 h. Cells were harvested and membranes prepared by two ultracentrifugation steps in 20 mM HEPES pH7.5, 1 mM EDTA, 1mM PMSF. NECA (100 μ M), NaCl (300 mM), PMSF (1mM) and Complete protease inhibitors (Roche) were added to the membranes, and the sample was mixed for 30 min at room temperature. Membranes from 3 l of cells were solubilized with 2% n-decyl-β -d-maltopyranoside (DM) on ice for 1 h. The sample was clarified by ultracentrifugation and loaded onto a 5 ml Ni-NTA column (Qiagen). The column was washed with wash buffer (20 mM HEPES pH 7.5, 500 mM NaCl, 10% glycerol, 80 mM imidazole, 100 μ M NECA, 0.15% DM), and eluted with elution buffer (20 mM HEPES pH 7.5, 100 mM NaCl, 10% glycerol, 300 mM imidazole, 100 μ M NECA, 0.15% DM). The eluate was concentrated using a 50 kDa cut-off Amicon centrifugal ultrafiltration unit (Millipore), and exchanged into desalting buffer (10 mM HEPES pH 7.5, 100 mM NaCl, 10% glycerol, 100 μ M NECA, 0.15% DM) using a PD10 column (GE Healthcare). TEV protease was added, and the sample was incubated on ice overnight. TEV protease was removed by negative purification on Ni 2+ -NTA resin. The sample was concentrated to 0.2 ml and loaded onto a Superdex 200 column (GE Healthcare). Peak fractions were pooled and concentrated to approximately 20 mg/ml. A typical yield was 2 mg of pure A 2A R per litre of culture. Complexation and crystallization. Purified A 2A R was mixed with a 1.2-fold molar excess of mini-G s . MgCl 2 (1 mM) and apyrase (0.1 U) were added, and the mixture was incubated on ice overnight. The sample was diluted tenfold in gel-filtration buffer (10 mM HEPES pH 7.5, 100 mM NaCl, 100 μ M NECA, 0.35% n-octyl-β -d-thioglucopyranoside OTG), concentrated to 0.2 ml, and loaded on to a Superdex 200 column (pre-equilibrated in the same buffer). Peak fractions, containing the A 2A R-mini-G s complex, were pooled and concentrated to 20 mg/ml. The A 2A R-mini-G s complex was crystallized by vapour diffusion in OTG either in the presence or absence of cholesterol hemisuccinate (CHS), but there was no discernible difference in the quality of crystals that grew under the two different conditions (the structure was determined using data collected from two crystals, one from each condition). Crystallization plates were set up at 4 °C using 120-nl sitting drops. Crystals used for structure solution were grown in two conditions, either: 0.1 M NaOAc pH 5.5, 10% PEG 2000 (in the presence of CHS); or 0.1 M NaOAc pH 5.7, 9.5% PEG 2000 MME (in the absence of CHS). Crystals were cryo-protected in mother liquor supplemented with 30% PEG 400 and flash frozen in liquid nitrogen. Data collection, processing and refinement. Diffraction data were collected at the European Synchrotron Radiation Facility on beamline ID23-2 with a Pilatus 2M detector, using a 6 μ m × 8 μ m microfocus beam (0.8729 Å wavelength). Data were collected using either standard or helical collection modes. Data from two crystals were used for structure solution. Data were processed using MOSFLM 25 and AIMLESS 26 . The structure was solved by molecular replacement with PHASER 27 using the structures of the thermostabilized A 2A R (PDB ID: 2YDV) 4 and the Gα s GTPase domain (residues 40-59 and 205-394) from the β 2 AR-G s complex (PDB ID: 3SN6) 3 as search models. Model refinement and rebuilding were performed using REFMAC 28 and COOT 29 . Competition binding assay. FreeStyle HEK293-F cells transiently expressing wild type A 2A R were resuspended in either assay buffer A (25 mM HEPES, pH 7.5, 100 mM KCl, 1 mM MgCl 2 ), assay buffer B (25 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM MgCl 2 ), or assay buffer C (25 mM HEPES, pH 7.5, 500 mM NaCl, 1 mM MgCl 2 ), and were lysed by 10 passages through a 26-gauge needle. Purified binding partners were buffer-exchanged to the respective buffer before being added to the membranes at a final concentration of 25 μ M. The mixture was aliquoted and NECA was added (0 to 1 mM final concentration, prepared in assay buffers containing 1 U/ml apyrase). The samples were incubated for 90 min at 22 °C, 3 H-ZM241385 was added at its apparent K d (2.5 nM) and allowed to bind for a further 90 min at 22 °C. Non-specific binding was determined in the presence of 100 μ M of ZM241385. Receptor-bound and free radioligand were separated by filtration through 96-well GF/B filter plates (pre-soaked with 0.1% polyethyleneimine), and washed three times with the appropriate buffer. Plates were dried and radioactivity was quantified by liquid scintillation counting using a Tri-Carb 2910 TR (Perkin Elmer). Data were analysed by nonlinear regression using GraphPad Prism software. The K i for NECA binding was derived from one-site fit K i analysis. Data from at least three independent experiments, each performed in duplicate, were analysed using an unpaired two-tailed t-test for statistical significance. Thermostability assay. Membranes from Trichoplusia ni cells expressing wildtype human A 2A R were resuspended in T m buffer (25 mM HEPES pH 7.5, 100 mM NaCl, 1 mM MgCl 2 ) and homogenized by ten passages through a 26-gauge needle. Binding partner was added at a final concentration of 25 μ M. 3 H-NECA and unlabelled NECA were mixed in a molar ratio of 1:5 and added to the membranes to give a final concentration of 1 μ M (approximately tenfold above the apparent K d ). The samples were incubated at room temperature for 1 h, then chilled on ice for 30 min. DDM, DM or OG were added to a final concentration of 0.1%, 0.13% or 0.8%, respectively, and samples were incubated on ice for 1 h. Cell debris and insoluble material were removed by centrifugation for 5 min at 20,000g and the supernatant was aliquoted into PCR strips. Samples were heated to the desired temperature for exactly 30 min, then quenched on ice for 30 min. Samples (50 μ l) were loaded onto gel-filtration resin packed into a 96-well filter plate (Millipore), which was centrifuged to separate receptor-bound from free radioligand. Nonspecific binding was determined in the presence of 200 μ M unlabelled NECA. Radioactivity was quantified by liquid scintillation counting using a MicroBeta TriLux scintillation counter (PerkinElmer). Data were analysed by nonlinear regression using GraphPad Prism software. Apparent T m values were derived from sigmoidal dose-response analysis. Results represent the mean ± s.e.m. of two independent experiments, performed in duplicate. 
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